Every generation arrives with its own cultural wiring, but Gen Alpha is the first to grow up in a world where interactivity isn’t a novelty, it’s the default. They learned to swipe before they could ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...